MedTrace Logo

A Study to Assess the Safety and Tolerability of E6742 in Japanese Healthy Adult Participants

NCT04683185 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2021-07-20

No results posted yet for this study

Summary

The primary purpose of the study is to evaluate the safety, tolerability and pharmacokinetics (PK) of multiple ascending oral doses of E6742 in Japanese healthy adult participants.

Conditions

  • Healthy Volunteers

Interventions

DRUG

E6742

E6742 tablets.

DRUG

Placebo

E6742-matched placebo tablets.

Sponsors & Collaborators

  • Eisai Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-28
Primary Completion
2021-06-21
Completion
2021-06-21

Countries

  • Japan

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04683185 on ClinicalTrials.gov